The concern regarding late-stent thrombosis with the use of drug-eluting, stents provides the basis for an examination of alternative approaches to stent design. This article outlines the biological mechanisms behind the thrombosis and hence provides a framework for understanding the types of drug actions that will be required for the next generation of stents.
|Pages (from-to)||30, 32-33|
|Number of pages||3|
|Journal||Medical Device Technology|
|Publication status||Published - 1 May 2007|
- stent design
- drug actions